Alimentiv is the premier global CRO specializing exclusively in gastroenterology. The company delivers end to end clinical trial services spanning protocol design, central endoscopy reading, medical imaging, biostatistics, regulatory strategy, and precision medicine. With over 30 years of experience, Alimentiv has supported more than 70% of IBD compounds in development. Job seekers join a team advancing GI science through validated endpoints and innovative trial designs. Operating across 60+ countries with access to 5,000+ sites, Alimentiv combines academic research legacy with operational excellence to accelerate treatments for inflammatory bowel disease, eosinophilic esophagitis, celiac disease, and other GI disorders.
450
Team Members
1986
Founded
Contract Research
Sector
Remote
Work Environment
A world where people living with gastrointestinal disorders have access to effective treatments that transform their quality of life, enabled by rigorous science and accelerated clinical development.
Alimentiv transforms the lives of people living with gastrointestinal disorders through pioneering research and innovative clinical trial development that advances GI science.